BlossomHill Therapeutics
About:
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Website: http://bhtherapeutics.com
Top Investors: OrbiMed, Cormorant Asset Management, Vivo Capital, Colt Ventures, Plaisance Capital Management
Description:
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
Total Funding Amount:
$173M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)bhtherapeutics.com
Founders:
J. Jean Cui, Y. Peter Li
Number of Employees:
11-50
Last Funding Date:
2024-01-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai